During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
A motorcyclist has died after a chase involving a UK-registered car ended in a police shoot-out and pile-up on a busy motorway in Belgium.
Leicester City manager Claudio Ranieri is confident of keeping his star names at the King Power Stadium next season.
Mourners have gathered for the funeral of army officer Capt David Seath who died after collapsing during the London Marathon.